当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析 - 现金流量表

宏源药业

(301246)

  

流通市值:30.24亿  总市值:70.00亿
流通股本:1.73亿   总股本:4.00亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金903,889,852.05259,322,027.831,023,470,542.97798,157,077.42
  收到的税费返还3,616,759.853,238,494.3724,931,822.624,837,813.63
  收到其他与经营活动有关的现金5,518,917.46,796,891.4371,221,535.1522,678,257.91
  经营活动现金流入小计913,025,529.3269,357,413.631,119,623,900.72845,673,148.96
  购买商品、接受劳务支付的现金603,690,634.05137,778,866.34956,127,643.01790,227,503.57
  支付给职工以及为职工支付的现金126,899,741.8271,352,928.2219,961,860.47163,503,294.83
  支付的各项税费87,603,464.732,158,716.954,268,753.7327,265,918.32
  支付其他与经营活动有关的现金55,314,908.3338,558,415.0774,227,669.6550,066,353.34
  经营活动现金流出小计873,508,748.9279,848,926.511,304,585,926.861,031,063,070.06
  经营活动产生的现金流量净额39,516,780.4-10,491,512.88-184,962,026.14-185,389,921.1
二、投资活动产生的现金流量:
  收回投资收到的现金1,787,816,190.42431,901,018.775,387,349,572.354,184,646,241.39
  取得投资收益收到的现金12,300,000---
  处置固定资产、无形资产和其他长期资产收回的现金净额952,457.52473,183.722,114,836.971,834,205.94
  投资活动现金流入小计1,801,068,647.94432,374,202.495,389,464,409.324,186,480,447.33
  购建固定资产、无形资产和其他长期资产支付的现金144,208,215.2657,100,870.27156,093,034.64131,292,020.47
  投资支付的现金1,895,961,828.76573,900,0005,474,000,0004,697,000,000
  投资活动现金流出小计2,040,170,044.02631,000,870.275,630,093,034.644,828,292,020.47
  投资活动产生的现金流量净额-239,101,396.08-198,626,667.78-240,628,625.32-641,811,573.14
三、筹资活动产生的现金流量:
  取得借款收到的现金220,641,422.4981,750,657.99504,553,476.5448,000,000
  收到其他与筹资活动有关的现金--78,545,949.5160,037,678.01
  筹资活动现金流入小计220,641,422.4981,750,657.99583,099,426.01508,037,678.01
  偿还债务支付的现金98,757,00022,777,000307,914,000133,054,000
  分配股利、利润或偿付利息支付的现金27,284,167.13,905,516.4928,071,456.1123,532,444.13
  支付其他与筹资活动有关的现金87,688,369.2444,364,909.8715,766,629.1915,346,726.32
  筹资活动现金流出小计213,729,536.3471,047,426.36351,752,085.3171,933,170.45
  筹资活动产生的现金流量净额6,911,886.1510,703,231.63231,347,340.71336,104,507.56
四、汇率变动对现金及现金等价物的影响-2,365,081.33-1,500,551.33-354,941.99581,007.55
五、现金及现金等价物净增加额-195,037,810.86-199,915,500.36-194,598,252.74-490,515,979.13
  加:期初现金及现金等价物余额387,588,125.28387,588,125.28582,186,378.02582,186,378.02
  期末现金及现金等价物余额192,550,314.42187,672,624.92387,588,125.2891,670,398.89
补充资料:
  净利润155,490,305.32-117,629,722.13-
  资产减值准备8,006,454.37-43,588,289.49-
  固定资产和投资性房地产折旧102,578,002.53-196,057,535.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧102,578,002.53-196,057,535.17-
  无形资产摊销2,771,688.62-5,457,289.29-
  长期待摊费用摊销1,246,885.9-2,686,474.6-
  处置固定资产、无形资产和其他长期资产的损失2,372,406.36--773,836.31-
  固定资产报废损失8,163,303.92-10,810,117.93-
  公允价值变动损失2,611,561.96--1,849,195.72-
  财务费用7,442,202.69-15,546,559.14-
  投资损失-38,073,357--30,104,189.56-
  递延所得税-259,650.77--2,297,864.27-
  其中:递延所得税资产减少292,653.87--2,408,607.98-
    递延所得税负债增加-552,304.64-110,743.71-
  存货的减少-60,614,273.92--54,126,972.35-
  经营性应收项目的减少-269,490,112.44--579,111,126.27-
  经营性应付项目的增加116,667,173.68-79,469,220.22-
  其他118,636.4-11,084,844.81-
  现金的期末余额192,550,314.42-387,588,125.28-
  减:现金的期初余额387,588,125.28-582,186,378.02-
  现金及现金等价物的净增加额-195,037,810.86--194,598,252.74-
公告日期2026-08-282026-04-292026-04-292025-10-23
审计意见(境内)标准无保留意见
TOP↑